← Back to Search

APPS Intervention for Domestic Violence Prevention (APPS Trial)

N/A
Waitlist Available
Led By Garen J Wintemute, MD, MPH
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults with records of firearms ownership who have experienced a prohibiting event. Prohibiting events are based in Federal and California state law. Among others, they include criminal convictions for felonies and selected violent misdemeanors; emergency hospitalization for dangerousness associated with severe mental illness, as specified in statute; and status as respondent to a domestic violence restraining order.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether the California system that stops people who have legally purchased firearms but are now prohibited from owning them from owning them, reduces the risk of future violence among those people.

Who is the study for?
This trial is for adults in California who previously bought firearms legally but can't own them anymore due to certain events like felony convictions, violent misdemeanors, mental illness-related hospitalizations, or being under a domestic violence restraining order.
What is being tested?
The study is testing the impact of California's Armed and Prohibited Persons System (APPS), which aims to reduce future violence by preventing individuals with prohibiting events from owning firearms.
What are the potential side effects?
Since this trial evaluates a legal intervention rather than a medical one, it does not have side effects in the traditional sense. The focus is on societal outcomes such as reduced risk of violence.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I own a firearm and have had a legal issue that prohibits me from owning it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of arrest for violent and firearm-related crimes
Secondary study objectives
Incidence of arrest for non-violent, non firearms-related crimes
Incidence of domestic violence restraining orders
Incidence of emergency mental health hospitalizations
Other study objectives
Community level rates of violence
Cost benefit analysis

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1Experimental Treatment1 Intervention
APPS intervention will be implemented in Group 1 communities prior to implementation in Group 2 communities.
Group II: Group 2Active Control1 Intervention
APPS intervention will be implemented in Group 2 communities following implementation in Group 1 communities.

Find a Location

Who is running the clinical trial?

Stanford UniversityOTHER
2,484 Previous Clinical Trials
17,496,121 Total Patients Enrolled
Northeastern UniversityOTHER
99 Previous Clinical Trials
51,076 Total Patients Enrolled
University of California, DavisLead Sponsor
945 Previous Clinical Trials
4,736,140 Total Patients Enrolled
Rutgers UniversityOTHER
121 Previous Clinical Trials
2,789,354 Total Patients Enrolled
Garen J Wintemute, MD, MPHPrincipal InvestigatorUniversity of California, Davis

Media Library

APPS intervention Clinical Trial Eligibility Overview. Trial Name: NCT02318732 — N/A
Domestic Violence Research Study Groups: Group 2, Group 1
Domestic Violence Clinical Trial 2023: APPS intervention Highlights & Side Effects. Trial Name: NCT02318732 — N/A
APPS intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT02318732 — N/A
~1846 spots leftby Dec 2025